(Credit-Canva)
Body odor is natural part of human physiognomy, while some people may experience less of it, it can be stronger in others. This odor is not uniform throughout your body, certain body part smell more, like your armpits, groin and feet. The Cleveland clinic explains that this smell is due to bacteria and smell on your skin. Your body odor can also change if you are on medication, or ate a certain food or even experience some hormonal changes.
Similarly, It's common for belly buttons to have a slight odor, but sometimes it can become noticeable and unpleasant. While a little smell is often nothing to worry about, a strong, foul odor, especially when combined with other symptoms, could be a sign of a more serious problem. It's important to understand the possible causes of a smelly belly button so you can take the right steps to address it. Knowing when to simply clean it better versus when to seek medical help is key to keeping yourself healthy.
If your belly button smells bad and you also have redness, swelling, pain, or bleeding, you should see a doctor. These symptoms could be a sign of an infection that needs medical treatment Here are some reasons why this may be happening.
Just like any other part of your body, your belly button needs regular cleaning. If you skip cleaning it with soap and water, things like dirt, sweat, and natural oils can build up inside. As explained above, his buildup creates a breeding ground for bacteria, which can lead to a musty or unpleasant smell. This is especially true if you have a deep belly button, as it has folds and crevices that are harder to reach and clean properly. A deep belly button is a warm, damp place, which is exactly what bacteria love.
Even if you take regular showers, your belly button can still collect things like dead skin cells, lint from your clothes, and other small pieces of debris. WebMD explains that these things can get trapped inside, and when mixed with moisture from sweat or water, they can start to smell bad. Sometimes, these things can clump together and form a hard, smelly lump called a navel stone. This stone can be quite smelly, even though it's usually not painful.
We all have bacteria on our skin, but sometimes they can cause infections. According to WebMD if bacteria get inside your belly button, especially through a small cut or scratch, they can multiply and cause an infection. Infections like impetigo and cellulitis can cause redness, swelling, pain, and pus, along with a bad smell. People with weak immune systems or poor blood flow are more likely to get these infections. If these infections are not treated, they can lead to serious problems, so it's important to see a doctor.
Yeast, which is a type of fungus, can also grow in your belly button, especially if it's warm and moist. According to the Cleveland Clinic a common type of yeast is Candida. Yeast infections can cause a sour, bread-like smell, along with redness and itching. Sweating a lot, wearing tight clothes, or taking antibiotics can increase your risk. People with diabetes or weak immune systems are also more likely to get yeast infections. These infections usually go away with antifungal creams, but it's important to keep the area dry to prevent them from coming back.
Cysts are small, fluid-filled bumps that can form under the skin. They can happen when dead skin cells and oils get trapped in your belly button. Most of the time, these cysts are harmless and don't cause any problems. But sometimes, they can become infected, which can cause them to swell, become red, and release a gray or white discharge with a cheesy smell. If a cyst gets infected, it might need to be drained by a doctor.
If you have a belly button piercing, it's very important to keep it clean. If you don't clean it properly, bacteria can build up around the piercing and cause an infection. Signs of an infection include pain, redness, swelling, and smelly pus. If the infection is not treated, it can spread to your bloodstream and cause serious health problems. Cleaning your piercing regularly with warm, soapy water can help prevent infections.
Credit: iStock
The liver and heart are two of the most vital organs of the body, and although they perform very different functions, they are closely connected. When the liver is not functioning properly, it can place significant stress on the heart and circulatory system of the body.
Liver disease not only affects the digestion process, metabolism, and detoxification but can also trigger serious cardiovascular changes that may go unnoticed in the early stages. Understanding this particular connection is significant for timely diagnosis and better overall care.
The liver helps to regulate the flow of blood, fluid balance, cholesterol metabolism, and inflammation as well. When liver disease develops—whether due to fatty liver, hepatitis, cirrhosis, or alcohol-related damage—all these processes become disturbed.
As a result of the same, the heart may have to work harder to maintain circulation, while blood vessels may also undergo certain changes that impact blood pressure and delivery of oxygen as well.
In well-advanced liver disease, especially cirrhosis, the flow of blood through the liver becomes restricted. This can also increase pressure in the portal vein, a condition known as portal hypertension. At the same point in time, blood vessels in the rest of the body may also widen, causing a drop in effective blood pressure.
To compensate, the heart pumps faster and harder. With the passage of time, this constant strain can weaken cardiac function and even lead to a condition sometimes referred to as cirrhotic cardiomyopathy, where the heart does not respond normally under stress.
Liver disease often causes the body to retain both salt and water. This can also lead to swelling in the legs, abdomen, and surrounding tissues as well. Extra fluid in the body increases the workload on the heart, making it more difficult for it to pump blood in an efficient way. In severe cases, this may also contribute to shortness of breath, fatigue, and worsening cardiovascular strain.
Some of the conditions, such as non-alcoholic fatty liver disease, are also linked with diabetes, obesity, high levels of cholesterol, and high blood pressure – all of which are the major risk factors for heart disease. Chronic inflammation, well-associated with liver damage, may further increase the risk of atherosclerosis and other cardiac complications.
Credit: iStock
GLP-1 receptor agonist drugs such as Ozempic and Wegovy have shown significant benefits for people with diabetes and obesity. However, not everyone experiences the same results.
Now, a study suggests that this variation may be due to genetic resistance, which means that some people are biologically less responsive to these medications, making these drugs less effective.
The new study by scientists at Stanford University in the US showed that about 10 per cent of the general population carry genetic variants that lead to what the researchers called “GLP-1 resistance”.
The GLP-1- receptor agonist drugs typically work by mimicking the hormone GLP-1 (glucagon-like peptide-1), which naturally helps regulate blood sugar by stimulating insulin release. The process slows the emptying of the stomach and reduces appetite.
However, in individuals with certain genetic variants, the team found that higher levels of GLP-1 did not regulate blood sugar better.
The researchers noted that the findings, published in the journal Genome Medicine, may be key to developing new therapies for people with GLP-1 resistance.
“There are a whole class of medications that are insulin sensitizers, so perhaps we can develop medications that will allow people to be sensitized to GLP-1s or find formulations of GLP-1, like the longer-acting versions, that avoid the GLP-1 resistance,” said Anna Gloyn, professor of pediatrics and of genetics at Stanford Medicine.
Also read: Foundayo: US FDA Approves Eli Lilly’s GLP-1 Weight Loss Pill
To zero in on the gene resistant to GLP-1 drugs, the team conducted experiments in humans. They traced this resistance to a PAM variant known as p.S539W.
PAM (peptidyl-glycine alpha-amidating monooxygenase) is an enzyme that is uniquely capable of activating many hormones in the body, including GLP-1.
While the researchers suspected that people with the PAM variant would have lower levels of GLP-1 in their blood, it actually increased levels of GLP-1. Although the exact mechanism is still unclear, experiments in both humans and mice confirmed signs of reduced response to GLP-1.
Analyzing diabetes drug trial data, they found that individuals with these variants were less able to lower their blood sugar levels even after six months of treatment. This suggests that despite having more circulating GLP-1, their bodies are less responsive to it.
“When I treat patients in the diabetes clinic, I see a huge variation in response to these GLP-1-based medications and it is difficult to predict this response clinically,” said Mahesh Umapathysivam, an endocrinologist and clinical researcher at Adelaide University in Australia.
“This is the first step in being able to use someone’s genetic make-up to help us improve that decision-making process,” he added.
Also read: Can Weight Loss Jabs Surge Divorce Rates? What Experts Are Saying
Importantly, participants with the PAM variants did not respond differently to other common diabetes treatments, including sulfonylureas, metformin, and DPP-4i.
The finding may help develop precision medicine, the researchers said. Knowing ahead of time who is likely to respond would help patients get on the right drugs faster, Gloyn said.
Ozempic is primarily indicated for type 2 diabetes management. But some doctors may prescribe it for weight loss in appropriate patients without diabetes.
Previous research has shown that medical conditions such as sleep apnea, along with certain common medications, such as antidepressants, steroids, and contraceptives, can hamper the process of shedding extra pounds.
Another major reason that can hamper weight loss is the side-effects of these drugs that can prompt a person to halt their prescription mid-way.
Credit: iStock
Once widely known as non-alcoholic fatty liver disease (NAFLD), the common and dangerous fatty liver condition was rephrased as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) due to its strong link to metabolic health issues like obesity and diabetes.
MASLD now includes patients with fatty liver disease linked to metabolic risk factors such as obesity, diabetes, and hypertension.
Globally, it was observed that all patients who have non-alcoholic fatty liver disease also have some associated form of metabolic dysfunction. The patients reported having either obesity, diabetes, metabolic syndrome, hypertension, or cholesterol problems.
And all these problems eventually lead to significant comorbidities later, like some people developed heart disease, while others developed complications of diabetes.
In view of these, a global consensus process in 2023 involving hundreds of experts from different countries adopted MASLD as it better reflected these underlying causes of the condition.
Also read: Lancet Study Shows Metabolic Liver Disease To Rise Over 38% By 2050: What’s Behind The Surge
MASLD is an umbrella term for liver conditions that develop in the presence of 1 or more cardiometabolic risk factors—including high blood sugar, elevated body mass index (BMI), and hypertension—but in the absence of other causes of liver fat accumulation.
The condition can be defined by excess liver fat accumulation (more than 5 per cent of liver weight) in the presence of metabolic dysfunction, independent of alcohol intake.
It encompasses a spectrum from simple steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma.
“Initially, it was thought that having fatty liver disease without alcohol was a benign condition, but now it is recognized that, since it is associated with lots of metabolic comorbidities, it's no longer benign,” Dr. Ashish Kumar, Professor of gastroenterology and hepatology at Sir Ganga Ram Hospital in New Delhi, told HealthandMe.
He stated that whenever a diagnosis of fatty liver is present, "we should actually include other comorbidities, like obesity, dyslipidemia, which means cholesterol problem, diabetes, sugar problem, pre-diabetes, and hypertension. At least 50–70–80 percent of these patients will have one or more of these comorbidities".
Although alcohol has remained the number one risk for liver disease, MASLD seems to be rising globally, including among people who do not drink. Why?
The reasons include:
a sedentary lifestyle,
increased consumption of fast and processed food,
lack of exercise,
lack of sleep,
stressful life.
Also read: Why Regular Scans Are Crucial for Liver Cancer Patients: Doctors Explain
The experts noted that food, especially the increasingly accessible junk food or processed food, is a major culprit.
“So even if the person is not drinking alcohol, people are developing addiction to processed food, and this is causing an epidemic level of obesity and diabetes. Consequently, MASLD is also increasing, and now it is becoming the number one cause of liver disease,” Dr Kumar said.
According to Dr. Sanjay Goja, Director, Liver Transplant & HPB Surgery, Narayana Hospital, Gurugram, prevention must focus on following a healthy lifestyle like maintaining a healthy BMI, engaging in regular physical activity, and eating a balanced diet.
Controlling diabetes, cholesterol, and blood pressure is also important to prevent the risk of MASLD.
Dr Siddharth Badola, Manipal Hospital, Ghaziabad, suggested sustainable lifestyle changes such as:
Maintaining an adequate body weight: Even slight weight loss (5–10 percent) has been shown to significantly reduce liver fat and inflammation.
Follow a balanced and nutrient-rich diet: People should focus on consuming whole grains, fresh fruits and vegetables, lean proteins, and healthy fats, while limiting refined carbohydrates and processed foods.
Avoid foods with added sugar: Excess consumption of fructose, commonly found in packaged foods and sugary beverages, is a key contributor to fat accumulation in the liver.
Engage in regular physical activity: At least 150 minutes of moderate-intensity exercise per week is recommended to improve insulin sensitivity and liver health.
Manage associated metabolic conditions: Effective control of diabetes, hypertension, and dyslipidemia is essential in reducing the risk of MASLD progression.
Ensure adequate sleep and stress management: Poor sleep quality and chronic stress can negatively impact metabolic balance and liver function.
Keep your body hydrated with ample water intake and follow structured meal timings.
© 2024 Bennett, Coleman & Company Limited